Avantor, Inc.
NYSE:AVTRMedical - Instruments & Supplies
+$0.07 today
- Market cap
- $10.41B
- Beta
- 0.96
- P/E (TTM)
- -11.7
- EPS (TTM)
- -$0.81
Volume 5.94M
Average 9.44M
AVTR Total Equity
Shareholders' claim on the company's assets after all liabilities: total assets minus total liabilities.
Avantor, Inc.NYSE: AVTR
Total Equity · Q2 FY2026 · quarter ended Jun 2026
Total equity falls 10.4% from a year ago
Total equity stood at $5.63B at the end of Q2 FY2026, down 10.4% from a year earlier and up 0.7% from the prior quarter. Over 3 fiscal years it compounded at +4.7% a year.
Context
- Total equity amounted to 48.6% of total assets at the end of Q2 FY2026, down 0.6 pp from a year earlier.
- Total equity increased in 2 of the last 3 fiscal years.
What to watch
Whether total equity keeps falling in the next quarterly balance sheet after a -10.4% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Equity history
USD · from the balance sheet
- Latest · FY2025
- 5.57B USD
- Year-over-year change
- -6.6%
- 4-year CAGR
- +7.3%
| Period | Period end | Total Equity | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 5.57B | -6.6% |
| FY2024 | 2024-12-31 | 5.96B | +13.4% |
| FY2023 | 2023-12-31 | 5.25B | +8.2% |
| FY2022 | 2022-12-31 | 4.86B | +15.7% |
| FY2021 | 2021-12-31 | 4.2B | — |
Total Equity vs competitors
How AVTR compares with its peers on the latest reported figures
- Peers report in different currencies, so total equity is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -10.4% is the 7th highest of 9, against a peer median of +2.3%.
- Total equity amounts to 48.6% of total assets for AVTR, versus a peer median of 70.8%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $53.63B USD | +5.0% | +1.6% | 57.5% | |
| Jun 2026 | $7.17B USD | +0.6% | -8.1% | 70.0% | |
| Jun 2026 | $5.63B USD | -10.4% | +4.7% | 48.6% | |
| Jun 2026 | $2.99B USD | +2.1% | +5.8% | 73.4% | |
| Jun 2026 | $2.85B USD | -16.3% | +2.0% | 37.8% | |
| Jun 2026 | $2.11B USD | +2.4% | +3.3% | 71.6% | |
| Jun 2026 | €1.55B EUR | +10.9% | +14.3% | 59.2% | |
| Sep 2026 | $1.4B USD | -18.9% | -18.0% | 81.8% | |
| Mar 2026 | $372.23M USD | +5.6% | +0.7% | 92.8% | |
| Peer median (excluding AVTR) | — | +2.3% | +1.8% | 70.8% | |
Competitors are the stored peer set for AVTR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 301.7M | 372.9M | 262.9M | 261.9M | 365.4M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 1.22B | 1.22B | 1.15B | 1.03B | 1.07B |
| Inventory | 872M | 913.5M | 828.1M | 731.5M | 818.2M |
| Other Current Assets | 81.4M | 153.1M | 143.7M | 118.7M | 193M |
| Total Current Assets | 2.48B | 2.66B | 2.38B | 2.15B | 2.45B |
| Property, Plant & Equipment (Net) | 705.5M | 727M | 737.5M | 708.1M | 766.8M |
| Goodwill | 5.34B | 5.65B | 5.72B | 5.54B | 4.99B |
| Intangible Assets | 5.14B | 4.13B | 3.78B | 3.36B | 3.19B |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 233.1M | 293.5M | 358.3M | 360.4M | 396M |
| Total Non-current Assets | 11.42B | 10.81B | 10.59B | 9.97B | 9.34B |
| Total Assets | 13.9B | 13.46B | 12.97B | 12.11B | 11.79B |
| Account Payables | 755.1M | 758.2M | 625.9M | 662.8M | 741.7M |
| Short-term Debt | 45.2M | 364.2M | 259.9M | 821.1M | 30.8M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 600.7M | 486.5M | 544.3M | 475M | 559.1M |
| Total Current Liabilities | 1.45B | 1.66B | 1.48B | 2.01B | 1.38B |
| Long-term Debt | 6.98B | 5.92B | 5.28B | 3.23B | 3.92B |
| Deferred Tax Liabilities | 913M | 731.4M | 612.8M | 557.3M | 557.1M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 358.4M | 295.4M | 350.3M | 358.3M | 378.2M |
| Total Non-current Liabilities | 8.25B | 6.95B | 6.24B | 4.15B | 4.85B |
| Total Liabilities | 9.7B | 8.61B | 7.72B | 6.16B | 6.23B |
| Common Stock | 2.75B | 3.79B | 3.83B | 3.94B | 3.98B |
| Retained Earnings | 483.9M | 1.17B | 1.49B | 2.2B | 1.67B |
| Accumulated OCI | (43.2M) | (100.3M) | (69M) | (184M) | (16.9M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 4.2B | 4.86B | 5.25B | 5.96B | 5.57B |
| Total Debt | 7.02B | 6.29B | 5.54B | 4.06B | 3.95B |
| Net Debt | 6.72B | 5.91B | 5.27B | 3.79B | 3.58B |
Avantor, Inc.
NYSE:AVTR
Intrinsic Alpha fair value
Locked
Current Price
$15.37
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.